Ferumoxytol-enhanced magnetic resonance imaging assessing inflammation after myocardial infarction
Colin G Stirrat, Shirjel R Alam, Thomas J MacGillivray, Calum D Gray, Marc R Dweck, Jennifer Raftis, William Sa Jenkins, William A Wallace, Renzo Pessotto, Kelvin Hh Lim, Saeed Mirsadraee, Peter A Henriksen, Scott Ik Semple, David E Newby, Colin G Stirrat, Shirjel R Alam, Thomas J MacGillivray, Calum D Gray, Marc R Dweck, Jennifer Raftis, William Sa Jenkins, William A Wallace, Renzo Pessotto, Kelvin Hh Lim, Saeed Mirsadraee, Peter A Henriksen, Scott Ik Semple, David E Newby
Abstract
Objectives: Macrophages play a central role in the cellular inflammatory response to myocardial infarction (MI) and predict subsequent clinical outcomes. We aimed to assess temporal changes in cellular inflammation and tissue oedema in patients with acute MI using ultrasmallsuperparamagnetic particles of iron oxide (USPIO)-enhanced MRI.
Methods: Thirty-one patients were recruited following acute MI and followed up for 3 months with repeated T2 and USPIO-enhanced T2*-mapping MRI. Regions of interest were categorised into infarct, peri-infarct and remote myocardial zones, and compared with control tissues.
Results: Following a single dose, USPIO enhancement was detected in the myocardium until 24 hours (p<0.0001). Histology confirmed colocalisation of iron and macrophages within the infarcted, but not the non-infarcted, myocardium. Following repeated doses, USPIO uptake in the infarct zone peaked at days 2-3, and greater USPIO uptake was detected in the infarct zone compared with remote myocardium until days 10-16 (p<0.05). In contrast, T2-defined myocardial oedema peaked at days 3-9 and remained increased in the infarct zone throughout the 3-month follow-up period (p<0.01).
Conclusion: Myocardial macrophage activity can be detected using USPIO-enhanced MRI in the first 2 weeks following acute MI. This observed pattern of cellular inflammation is distinct, and provides complementary information to the more prolonged myocardial oedema detectable using T2 mapping. This imaging technique holds promise as a non-invasive method of assessing and monitoring myocardial cellular inflammation with potential application to diagnosis, risk stratification and assessment of novel anti-inflammatory therapeutic interventions.
Trial registration number: Trial registration number: 14663. Registered on UK Clinical Research Network (http://public.ukcrn.org.uk) and also ClinicalTrials.gov (https://ichgcp.net/clinical-trials-registry/NCT02319278?term=DECIFER&rank=2).
Keywords: Cardiac; Inflammation; MRI; Molecular Imaging; Myocardial Infarction; USPIO.
Conflict of interest statement
Competing interests: None declared.
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.
Figures
References
- As G, Mozaffarian D, Roger VL, et al. . Heart disease and stroke statistics—2014 update: a report from the – PubMed – NCBI. Circulation 2014;129:e28–92.
- Nahrendorf M, Swirski FK, Aikawa E, et al. . The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007;204:3037–47. 10.1084/jem.20070885
- Nahrendorf M, Pittet MJ, Swirski FK. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 2010;121:2437–45. 10.1161/CIRCULATIONAHA.109.916346
- Panizzi P, Swirski FK, Figueiredo JL, et al. . Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol 2010;55:1629–38. 10.1016/j.jacc.2009.08.089
- Tsujioka H, Imanishi T, Ikejima H, et al. . Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol 2009;54:130–8. 10.1016/j.jacc.2009.04.021
- Ruehm SG, Corot C, Vogt P, et al. . Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415–22. 10.1161/01.CIR.103.3.415
- Alam SR, Shah AS, Richards J, et al. . Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experience. Circ Cardiovasc Imaging 2012;5:559–65. 10.1161/CIRCIMAGING.112.974907
- Yilmaz A, Dengler MA, van der Kuip H, et al. . Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Eur Heart J 2013;34:462–75. 10.1093/eurheartj/ehs366
- Abdel-Aty H, Zagrosek A, Schulz-Menger J, et al. . Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation 2004;109:2411–6. 10.1161/01.CIR.0000127428.10985.C6
- Kellman P, Aletras AH, Mancini C, et al. . T2-prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo. Magn Reson Med 2007;57:891–7. 10.1002/mrm.21215
- Thygesen K, Alpert JS, Jaffe AS, et al. . Third universal definition of myocardial infarction. Jac 2012;60:1581–98.
- Taylor AM, Panting JR, Keegan J, et al. . Safety and preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography. J Magn Reson Imaging 1999;9:220–7. 10.1002/(SICI)1522-2586(199902)9:2<220::AID-JMRI11>;2-A
- Thorek DL, Chen AK, Czupryna J, et al. . Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 2006;34:23–38. 10.1007/s10439-005-9002-7
- Van Beers BE, Sempoux C, Materne R, et al. . Biodistribution of ultrasmall iron oxide particles in the rat liver. J Magn Reson Imaging 2001;13:594–9. 10.1002/jmri.1083
- Lee WW, Marinelli B, van der Laan AM, et al. . PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 2012;59:153–63. 10.1016/j.jacc.2011.08.066
- Stirrat CG, Alam SR, MacGillivray TJ, et al. . Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T. J Cardiovasc Magn Reson 2016;18:46 10.1186/s12968-016-0261-2
- Verhaert D, Thavendiranathan P, Giri S, et al. . Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging 2011;4:269–78. 10.1016/j.jcmg.2010.09.023
- Giri S, Chung YC, Merchant A, et al. . T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009;11:56 10.1186/1532-429X-11-56
- Dall’Armellina E, Karia N, Lindsay AC, et al. . Dynamic changes of edema and late gadolinium enhancement after acute myocardial infarction and their relationship to functional recovery and salvage index. Circ Cardiovasc Imaging 2011;4:228–36. 10.1161/CIRCIMAGING.111.963421
- Nilsson JC, Nielsen G, Groenning BA, et al. . Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart 2001;85:639–42. 10.1136/heart.85.6.639
- Alam SR, Lewis SC, Zamvar V, et al. . Perioperative elafin for ischaemia-reperfusion injury during coronary artery bypass graft surgery: a randomised-controlled trial. Heart 2015;101:1639–45. 10.1136/heartjnl-2015-307745
Source: PubMed